ENTELLUS MED INC's ticker is ENTL and the CUSIP is 29363K105. A total of 73 filers reported holding ENTELLUS MED INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,597,000 | -61.2% | 65,482 | -70.6% | 0.02% | -62.5% |
| Q3 2017 | $4,118,000 | +7.4% | 223,073 | -3.7% | 0.06% | +5.7% |
| Q2 2017 | $3,836,000 | +28.0% | 231,656 | +6.7% | 0.05% | +20.5% |
| Q1 2017 | $2,997,000 | -20.9% | 217,194 | +8.8% | 0.04% | -22.8% |
| Q4 2016 | $3,789,000 | -14.5% | 199,717 | -0.0% | 0.06% | -13.6% |
| Q3 2016 | $4,430,000 | +33.6% | 199,731 | +10.0% | 0.07% | +29.4% |
| Q2 2016 | $3,317,000 | +34.5% | 181,581 | +28.3% | 0.05% | +34.2% |
| Q1 2016 | $2,467,000 | +3.4% | 141,557 | +0.0% | 0.04% | +15.2% |
| Q4 2015 | $2,386,000 | +16.4% | 141,512 | +24.4% | 0.03% | +22.2% |
| Q3 2015 | $2,050,000 | -17.9% | 113,746 | +17.8% | 0.03% | 0.0% |
| Q2 2015 | $2,498,000 | +46.3% | 96,577 | +23.8% | 0.03% | +50.0% |
| Q1 2015 | $1,708,000 | – | 78,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,956,456 | $48,960,000 | 52.70% |
| Discovery Group I, LLC | 2,169,729 | $35,931,000 | 10.38% |
| Essex Woodlands Management, Inc. | 3,231,656 | $53,516,000 | 9.68% |
| Archon Capital Management LLC | 478,820 | $7,929,000 | 6.46% |
| First Light Asset Management, LLC | 512,416 | $8,486,000 | 2.85% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 341,468 | $5,655,000 | 2.15% |
| Ghost Tree Capital, LLC | 375,000 | $6,210,000 | 1.29% |
| PERKINS CAPITAL MANAGEMENT INC | 68,316 | $1,131,000 | 1.25% |
| Cypress Capital Management LLC (WY) | 63,540 | $1,052,222,000 | 1.21% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 35,000 | $580,000 | 0.66% |